A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thrombophilia Panel 1-No Meds (Client 2170, 3788, 55114, 57947)
Test Code9745CP
CPT Codes
85307, 85300, 85730, 85613, 81240, 85384, 83090, 83695, 85303, 85306, 85240
Includes
If the PTT-LA test is prolonged (>40 seconds), the Hexagonal Phase Confirm is performed at an additional charge.
If the Hexagonal Phase Confirm is positive or weakly positive, a Thrombin Clotting Time will be performed at an additional charge.
If the dRVVT screen is prolonged (>45 seconds), the dRVVT Confirm is performed at an additional charge.
If the dRVVT Confirm is positive, a dRVVT 1:1 Mix will be performed at an additional charge.
If the Hexagonal Phase Confirm is positive or weakly positive, a Thrombin Clotting Time will be performed at an additional charge.
If the dRVVT screen is prolonged (>45 seconds), the dRVVT Confirm is performed at an additional charge.
If the dRVVT Confirm is positive, a dRVVT 1:1 Mix will be performed at an additional charge.
Preferred Specimen
11 mL plasma collected in a 3.2% sodium citrate (lt. blue-top) and 10 mL whole blood collected in EDTA (lavender-top) and 2 mL plasma collected in EDTA (lavender-top) tube
Minimum Volume
Citrated plasma: 1 mL
Whole blood: 5 mL
EDTA plasma: 5.5 mL
Whole blood: 5 mL
EDTA plasma: 5.5 mL
Instructions
See individual assays
Transport Temperature
Citrated plasma: Frozen
Whole blood: Room temperature
EDTA plasma: Refrigerated (cold packs)
Whole blood: Room temperature
EDTA plasma: Refrigerated (cold packs)
Specimen Stability
Plasma
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Whole blood
Room temperature: 8 days
Refrigerated: 8 days
Frozen: 30 days
Plasma
Room temperature: 4 days
Refrigerated: 14 days
Frozen: 90 days
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Whole blood
Room temperature: 8 days
Refrigerated: 8 days
Frozen: 30 days
Plasma
Room temperature: 4 days
Refrigerated: 14 days
Frozen: 90 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis • Unseparated serum or plasma • Grossly lipemic • Grossly icteric
Methodology
See individual assays
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
See individual assays
Clinical Significance
See individual assays